MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO. – Trademark Portfolio

Entity Type: 03

MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ACHE-AWAY. The owner is based in OAK PARK, MI.

24050 MARLOW

OAK PARK, MI 48237

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ACHE-AWAY
ACHE-AWAY
Registered 1987

Trademark Classifications

MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO. have?

MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO. file in?

MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO.'s most well-known trademarks?

MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO.'s registered trademark portfolio includes well-known marks such as ACHE-AWAY. These are among 1 currently registered trademark in the portfolio.

What is MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO.'s trademark registration success rate?

MT. CLEMENS MINERAL OINTMENT, SALVE & BALM CO. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.